Principia BioPharma
A biopharmaceutical company developing oral small molecule therapies for the treatment of cancer and autoimmune diseases
2
Funding Rounds
$62.5m
Money raised
Funding series
Funding Series Analysis
The company Principia BioPharma has raised a total of $12.5m in funding over 2 rounds.
Key Insights:
- Principia BioPharma Series A round: $12.5m
- Principia BioPharma Series B round April 2014: $50m
Principia BioPharma Series A round
$12.5m
Principia BioPharma Series B round April 2014
$50m
Industries
Principia BioPharma is active in the following industries:
- Technology
- Biotechnology
- Engineering
- Autoimmune disease
- Biomedical engineering
- Biology